Jonathan Ward

Title: Jonathan Ward and Tissue-Selective Transgene Expression.

Introduction

Jonathan Ward is an inventor based in Wetzikon, Switzerland. His patent work includes a method designed to control the expression of transcribable units in target cells.

Latest Patents

Ward is associated with 1 patent, titled “Tissue Selective Transgene Expression.” The method describes introducing a DNA vector into a target cell that expresses a site-specific recombinase. The vector contains multiple recombination units, each with at least one transcribable unit and two types of recombinase-recognized target sites. Recombination occurs only between target sites of the same type. The sites are arranged at opposite ends of each unit, with their orientations consistent across the vector. This design provides a framework for selective expression of transcribable units in the target cell.

Career Highlights

Ward is associated with Genome Biologics UG. His patent focuses on a genetic engineering approach that uses recombinase-mediated DNA rearrangement to regulate transgene expression.

Collaborations

Ward’s listed coworker is Jaya Krishnan. The available information identifies their association but does not specify the nature or scope of their collaboration.

Conclusion

Jonathan Ward’s patent describes a vector-based method for directing transgene expression in target cells, reflecting his work in genetic engineering and biotechnology.